Suchergebnisse - "Drake, Marcus J"

PubPharm (10)

1

Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re : Cosimo De Nunzio, Benjamin Brucker, Thomas Bschleipfer, et al. Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men. Eur Urol 2021;79:492-504

enthalten in: European urology | 2021

von De Nunzio, C. | Brucker, B. | Bschleipfer, T. | +9

CommentOn: Eur Urol. 2021 Apr;79(4):492-504. - PMID 33402296

2

Beyond Antimuscarinics : A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men

enthalten in: European urology | 2021

von De Nunzio, C. | Brucker, B. | Bschleipfer, T. | +9

CommentIn: Eur Urol. 2021 Apr;79(4):505-506. - PMID 33483177

3

Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin : A Prespecified Analysis from the BESIDE Study

enthalten in: European urology focus | 2017

von Gibson, W. | MacDiarmid, S. | Huang, M. | +4

4

Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Postvoid Residual Volume or Urinary Retention Risk

enthalten in: Urology | 2017

von Drake, M. | MacDiarmid, S. | Al-Shukri, S. | +6

5

A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands

enthalten in: BMC urology | 2017

von Drake, M. | Bowditch, S. | Arbe, E. | +4

CommentIn: J Urol. 2018 Nov;200(5):919. - PMID 30360295

6

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)

enthalten in: International journal of clinical practice | 2017

von Drake, M. | MacDiarmid, S. | Chapple, C. | +8

7

Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy : Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected

enthalten in: The Journal of urology | 2016

von MacDiarmid, S. | Al-Shukri, S. | Barkin, J. | +12

CommentIn: Nat Rev Urol. 2016 Jun;13(6):298-9. - PMID 27142125

8

Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms : results from the NEPTUNE Study and NEPTUNE II open-label extension

enthalten in: European urology | 2015

von Drake, M. | Chapple, C. | Sokol, R. | +6

CommentIn: Eur Urol. 2015 Feb;67(2):271-2. - PMID 25457016

9

Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men : efficacy and safety results from the randomised controlled NEPTUNE trial

enthalten in: European urology | 2013

von van Kerrebroeck, P. | Chapple, C. | Drogendijk, T. | +106

CommentIn: Nat Rev Urol. 2013 Sep;10(9):496. - PMID 23958830

10

Emerging drugs for treatment of overactive bladder and detrusor overactivity

enthalten in: Expert opinion on emerging drugs | 2008

von Drake, M.

1
[1]